<strong>Objective</strong><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><strong>:</strong...<strong>Objective</strong><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><strong>:</strong></span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> To summarize the nursing experience of induced labor of upper gastrointestinal bleeding in pregnancy complicated with decompensated cirrhosis. </span><b><span style="font-family:Verdana;">Methods</span></b></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> To treat two pregnant women with upper gastrointestinal bleeding complicated with decompensated cirrhosis with early labor induction, strengthen the nursing of upper gastrointestinal bleeding before </span><span style="font-family:Verdana;">operation</span><span style="font-family:Verdana;">, monitor changes of the patient</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">’</span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">s condition closely after </span><span style="font-family:Verdana;">operation</span><span style="font-family:Verdana;">, and strengthen</span></span></span></span><span><span><span style="font-family:""> </span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">the prevention and treatment of postpartum complications and health guidance. </span><b><span style="font-family:Verdana;">Results</span></b></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> No serious complications occurred in the 2 patients after </span><span style="font-family:Verdana;">operation</span><span style="font-family:Verdana;">. They were hospitalized for 11 and 17 days after </span><span style="font-family:Verdana;">operation</span><span style="font-family:Verdana;"> and were discharged stably. </span><b><span style="font-family:Verdana;">Conclusion</span></b></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> The pregnant women with upper gastrointestinal bleeding complicated with decompensated cirrhosis should terminate pregnancy in time and strengthen perinatal nursing, which can improve the liver function and blood coagulation and improve the prognosis of the patients.</span></span></span>展开更多
Objective: to analyze the clinical efficacy of etacridine combined with mifepristone (MFP) in the treatment of induced labor during middle pregnancy. Methods: from May 2015 to April 2020, 50 patients with midterm preg...Objective: to analyze the clinical efficacy of etacridine combined with mifepristone (MFP) in the treatment of induced labor during middle pregnancy. Methods: from May 2015 to April 2020, 50 patients with midterm pregnancy during labor induction period in our hospital were selected. The digital table was randomly divided into two groups with 25 cases in each group. Treatment was given to patients from a single drug group. The etazidine-bound group was treated with etazidine, acridine combined with MFP. The time, success rate, and incidence of complications were compared between the two groups from the start of dosing to embryo excretion. Results: the duration from initial administration to embryo expulsion in combination group was 36.21±2.45h shorter than that in single drug group, 56.13±5.01h, P < 0.05. The combined power was 100.00% higher than that of the single drug group (76.00%, P < 0.05). There were no serious complications in the two groups, including 2 cases of low fever in the monotherapy group and 3 cases of mild diarrhea and nausea in the combination group (P > 0.05). Conclusion: the clinical effect of ethacridine combined with MFP in the treatment of induced labor in the second trimester is better than ethacridine, which can improve the success rate and shorten the time of induced labor, with high safety.展开更多
Objective: to evaluate the effect and significance of different drugs (low-dose misoprostol and oxytocin) used in full-term pregnant women with premature rupture of membranes. Methods: 100 full-term pregnant women wit...Objective: to evaluate the effect and significance of different drugs (low-dose misoprostol and oxytocin) used in full-term pregnant women with premature rupture of membranes. Methods: 100 full-term pregnant women with premature rupture of membranes treated in Dingzhou Maternal and Child Health Hospital (January 2020-June 2022) were selected. According to the simple random sampling method, the selected 100 patients were equally divided into two groups. 50 pregnant women in the control group were given oxytocin to induce labor, and 50 pregnant women in the observation group were given low-dose misoprostol to induce labor. The success rate of induced labor, clinical indicators Apgar medication, incidence of adverse events, and comparison were made. Results: the success rate of induced labor in the observation group was 96.00%, which was significantly higher than that in the control group (84.00%, P < 0.05). Compared with the control group, the time from medication to labor, the time from medication to delivery and the total labor process in the observation group were all shorter, and the postpartum hemorrhage was less than that in the control group (P < 0.05). The total incidence of amniotic fluid pollution, fetal distress, excessive uterine contraction and intrauterine infection in the observation group was 6.00%, which was significantly lower than that in the control group (20.00%, P < 0.05). One minute after birth, the skin color, heart rate, reaction, muscle tension and respiration of newborns in the observation group were higher than those in the control group (P < 0.05). Six hours after treatment, the levels of PGE and E2 in the observation group were higher than those in the control group, and the levels of P were lower than those in the control group (P < 0.05). Conclusion: the application effect and value of low-dose misoprostol in full-term pregnant women with premature rupture of membranes is obviously higher than that of oxytocin, which can improve the success rate of induced labor, optimize the clinical indicators after medication, reduce the incidence of adverse events, increase Apgar score of newborns and improve hormone levels after treatment. It is worthy of recommendation and application.展开更多
文摘<strong>Objective</strong><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><strong>:</strong></span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> To summarize the nursing experience of induced labor of upper gastrointestinal bleeding in pregnancy complicated with decompensated cirrhosis. </span><b><span style="font-family:Verdana;">Methods</span></b></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> To treat two pregnant women with upper gastrointestinal bleeding complicated with decompensated cirrhosis with early labor induction, strengthen the nursing of upper gastrointestinal bleeding before </span><span style="font-family:Verdana;">operation</span><span style="font-family:Verdana;">, monitor changes of the patient</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">’</span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">s condition closely after </span><span style="font-family:Verdana;">operation</span><span style="font-family:Verdana;">, and strengthen</span></span></span></span><span><span><span style="font-family:""> </span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">the prevention and treatment of postpartum complications and health guidance. </span><b><span style="font-family:Verdana;">Results</span></b></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> No serious complications occurred in the 2 patients after </span><span style="font-family:Verdana;">operation</span><span style="font-family:Verdana;">. They were hospitalized for 11 and 17 days after </span><span style="font-family:Verdana;">operation</span><span style="font-family:Verdana;"> and were discharged stably. </span><b><span style="font-family:Verdana;">Conclusion</span></b></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><b><span style="font-family:Verdana;">:</span></b></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> The pregnant women with upper gastrointestinal bleeding complicated with decompensated cirrhosis should terminate pregnancy in time and strengthen perinatal nursing, which can improve the liver function and blood coagulation and improve the prognosis of the patients.</span></span></span>
文摘Objective: to analyze the clinical efficacy of etacridine combined with mifepristone (MFP) in the treatment of induced labor during middle pregnancy. Methods: from May 2015 to April 2020, 50 patients with midterm pregnancy during labor induction period in our hospital were selected. The digital table was randomly divided into two groups with 25 cases in each group. Treatment was given to patients from a single drug group. The etazidine-bound group was treated with etazidine, acridine combined with MFP. The time, success rate, and incidence of complications were compared between the two groups from the start of dosing to embryo excretion. Results: the duration from initial administration to embryo expulsion in combination group was 36.21±2.45h shorter than that in single drug group, 56.13±5.01h, P < 0.05. The combined power was 100.00% higher than that of the single drug group (76.00%, P < 0.05). There were no serious complications in the two groups, including 2 cases of low fever in the monotherapy group and 3 cases of mild diarrhea and nausea in the combination group (P > 0.05). Conclusion: the clinical effect of ethacridine combined with MFP in the treatment of induced labor in the second trimester is better than ethacridine, which can improve the success rate and shorten the time of induced labor, with high safety.
文摘Objective: to evaluate the effect and significance of different drugs (low-dose misoprostol and oxytocin) used in full-term pregnant women with premature rupture of membranes. Methods: 100 full-term pregnant women with premature rupture of membranes treated in Dingzhou Maternal and Child Health Hospital (January 2020-June 2022) were selected. According to the simple random sampling method, the selected 100 patients were equally divided into two groups. 50 pregnant women in the control group were given oxytocin to induce labor, and 50 pregnant women in the observation group were given low-dose misoprostol to induce labor. The success rate of induced labor, clinical indicators Apgar medication, incidence of adverse events, and comparison were made. Results: the success rate of induced labor in the observation group was 96.00%, which was significantly higher than that in the control group (84.00%, P < 0.05). Compared with the control group, the time from medication to labor, the time from medication to delivery and the total labor process in the observation group were all shorter, and the postpartum hemorrhage was less than that in the control group (P < 0.05). The total incidence of amniotic fluid pollution, fetal distress, excessive uterine contraction and intrauterine infection in the observation group was 6.00%, which was significantly lower than that in the control group (20.00%, P < 0.05). One minute after birth, the skin color, heart rate, reaction, muscle tension and respiration of newborns in the observation group were higher than those in the control group (P < 0.05). Six hours after treatment, the levels of PGE and E2 in the observation group were higher than those in the control group, and the levels of P were lower than those in the control group (P < 0.05). Conclusion: the application effect and value of low-dose misoprostol in full-term pregnant women with premature rupture of membranes is obviously higher than that of oxytocin, which can improve the success rate of induced labor, optimize the clinical indicators after medication, reduce the incidence of adverse events, increase Apgar score of newborns and improve hormone levels after treatment. It is worthy of recommendation and application.
